Copied
 
 
Formål
HistorikStartStop
Selskabets formål er at drive virksomhed med salg af laboratorieudstyr til danske og internationale kunder12.05.201423.03.2021
Virksomheden har ikke ændret Formål i sin levetid.
Ingen nuværende registrering.
Status
HistorikStartStop
OPLØST EFTER KONKURS23.03.202123.03.2021
UNDER KONKURS02.10.201822.03.2021
NORMAL04.06.200901.10.2018
Ingen nuværende registrering.
Branche
HistorikStartStop
Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (325000)05.07.201623.03.2021
Agenturhandel med maskiner, teknisk udstyr, skibe og flyvemaskiner (461400)15.06.200904.07.2016
Uoplyst (999999)04.06.200914.06.2009
Ingen nuværende registrering.
Revision
HistorikStartStop
false04.06.200923.03.2021
Virksomheden har ikke ændret Revision i sin levetid.
Ingen nuværende registrering.
Revisor
HistorikStartStop
EY Godkendt Revisionspartnerselskab26.03.201302.10.2018
Thorbjørn Helmo Madsen.04.06.200926.03.2013
Ingen nuværende registrering.
Form
HistorikStartStop
8004.06.200923.03.2021
Virksomheden har ikke ændret Form i sin levetid.
Ingen nuværende registrering.
Kontakt
HistorikStartStop
is@labogene.com20.11.201323.03.2021
Virksomheden har ikke ændret Kontakt i sin levetid.
Ingen nuværende registrering.
Telefon
HistorikStartStop
3940256604.11.201323.03.2021
3016099016.06.200903.11.2013
Ingen nuværende registrering.
Navne
Ingen nuværende registrering.
Binavne
HistorikStartStop
SCAN VAC ApS04.06.200923.03.2021
SCANLAF ApS04.06.200923.03.2021
Ingen nuværende registrering.
Tegningsregel
HistorikStartStop
Selskabet tegnes af en direktør i forening med selskabets formand12.05.201402.10.2018
Virksomheden har ikke ændret Tegningsregel i sin levetid.
Ingen nuværende registrering.
Ansatte
04.06.2024
Kapital
04.06.2024
Fra årsrapport
Type af revisorbistand:Revisionspåtegning
Virksomhedens regnskabsklasse:Regnskabsklasse B
Grundlag for konklusion (revision):We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Independence We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' Code of Ethics for Professional Accountants (IESBA Code) and the additional requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these rules and requirements.
Konklusion (revision):We have audited the financial statements of LaboGene ApS for the financial year 1 January - 31 December 2017, which comprise income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2017 and of the results of the Company's operations for the financial year 1 January - 31 December 2017 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
Bibranche
Ingen nuværende registrering.
Ingen historik.
Børsnoteret
04.06.2024
Ingen nuværende registrering.
Ingen historik.
Hjemmeside
04.06.2024
Ingen nuværende registrering.
Ingen historik.